Imeik Technology Development Co Ltd Class A
300896: XSHE (CHN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|jP | LOCK|QxTP | LOCK|^JkK&Gz |
Imeik Faces Weaker Demand and Rising Selling Costs
Business Strategy and Outlook
Imeik produces medical aesthetic fillers with two main segments, gel and solution, primarily in China. Historically dominated by foreign brands, domestic brands like Imeik have increased market share as they gain consumer acceptance. Given Imeik’s established brand and distribution network, we expect it to benefit greatly from the growing medical aesthetic penetration in China.
